Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge (vol 72, pg 2035, 2017)



Elliot, Emilie R, Amara, Alieu ORCID: 0000-0002-1137-2948, Pagani, Nicole, Else, Laura, Moyle, Graeme, Schoolmeesters, Alex, Higgs, Chris, Khoo, Saye ORCID: 0000-0002-2769-0967 and Boffito, Marta
(2017) Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge (vol 72, pg 2035, 2017) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 72 (7). p. 2143. ISSN 0305-7453, 1460-2091

[thumbnail of Elliot E_Once daily atazanavircobicistat and darunavircobicistat exposure over 72 hours post dose in plasma, urine and saliva, contribution to drug pharmacokinetic knowledge V3.0_copy.pdf] Text
Elliot E_Once daily atazanavircobicistat and darunavircobicistat exposure over 72 hours post dose in plasma, urine and saliva, contribution to drug pharmacokinetic knowledge V3.0_copy.pdf - Author Accepted Manuscript

Download (530kB) | Preview

Abstract

In Table 2 of the original published version of this article the entry in the 30 h column for 'Darunavir (ng/mL), GM (range)' was incorrectly given as '382 (97-257)'. The correct entry is '382 (97-2057)'. This error has nowbeen corrected.

Item Type: Article
Uncontrolled Keywords: 3214 Pharmacology and Pharmaceutical Sciences, 32 Biomedical and Clinical Sciences
Depositing User: Symplectic Admin
Date Deposited: 21 Feb 2020 14:01
Last Modified: 16 Jun 2026 07:02
DOI: 10.1093/jac/dkx145
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3007732
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.